OpGen’s subsidiary releases new features to its AREScloud offering

OpGen and OpGen subsidiary, Ares Genetics, announced a major feature upgrade for the AREScloud platform that has been implemented with our healthcare clients to enhance genomic surveillance. These specific new AREScloud features include: a new single nucleotide polymorphism analysis module designed to support continuous analysis of new isolates as part of an ongoing genomic surveillance program, a new module for interpretation of genetic elements such as plasmids responsible for horizontal gene transmission, results reporting specifically for the needs of hospital epidemiologists and infection prevention staff, and compliance with HIPAA and SOCS2 standards, with auditing expected to be completed in Q3. The new AREScloud features are now deployed as part of the standard analysis package, and in use with our customers globally. This includes a genomic surveillance contract with a large U.S. hospital network where we provide systematic sequencing and analysis of pathogen isolates on a weekly basis through our ARESiss service in Rockville, Maryland and AREScloud analysis. The new features further broaden the capabilities of AREScloud for microbial genomics that include antimicrobial resistance profiling, and genomic antibiotic sensitivity testing. For its sequencing service customers, AREScloud is also included as part of the ARESiss send-out service available through our laboratories in Rockville, Maryland and Vienna, Austria.